L.D. Mayer - Concepedia

Author

L.D. Mayer

University of British Columbia

Also Known As

L D Mayer, L MAYER, L Mayer, L. D. Mayer, L. De Mayer, L. Mayer, L.D. Mayer, LD Mayer, Lawrence D. Mayer

Publications

4.9K

Citations

H-Index

Concepts

All Affiliations

University of British Columbia BC Cancer Agency Celator Pharmaceuticals (Canada)

About

L.D. Mayer is an author at University of British Columbia specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	3.1K
2	Biochemistry	3	3	150
3	Engineering	2	2	1.8K
4	Health Sciences	2	2	109
5	Public Health	1	1	64

L.D. Mayer

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Vesicles of variable sizes produced by a rapid extrusion procedure L.D. Mayer, Michael J. Hope, Pieter R. Cullis Biochimica et Biophysica Acta (BBA) - Biomembranes EngineeringExtracellular MicrovesiclesBiomedical EngineeringRapid Extrusion ProcedureVesicle Biology	1986	1.7K
Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles L.D. Mayer, Michael J. Hope, Pieter R. Cullis, Biochimica et Biophysica Acta (BBA) - Biomembranes Experimental BiophysicsMembrane SystemBiophysicsSolute Distributions	1985	431
Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient L.D. Mayer, Marcel B. Bally, P.R. Cullis Biochimica et Biophysica Acta (BBA) - Biomembranes MedicineMembrane TransportAntibiotic AdjuvantPh GradientLarge Unilamellar Vesicles	1986	372
Generation of multilamellar and unilamellar phospholipid vesicles Michael J. Hope, Marcel B. Bally, L.D. Mayer, Chemistry and Physics of Lipids Membrane SystemUnilamellar Phospholipid VesiclesLipid MovementMolecular Biology	1986	346
Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models MS Webb, TO Harasym, Dana Masin, British Journal of Cancer Tumor BiologyMedicineTherapeutic PropertiesTumor TargetingAnti-cancer Agent	1995	240
Liposomal and Nonliposomal Drug Pharmacokinetics after Administration of Liposome-Encapsulated Vincristine and Their Contribution to Drug Tissue Distribution Properties R. Krishna, Murray S. Webb, Ginette St.-Onge, Journal of Pharmacology and Experimental Therapeutics	2001	129
Liposomal vincristine which exhibits increased drug retention and increased circulation longevity cures mice bearing P388 tumors. Nancy L. Boman, Dana Masin, L.D. Mayer, PubMed Pharmaceutical ScienceDrug TargetingP388 TumorsOxysterolMedicine	1994	126
Analysis of the effect of liposome encapsulation on the vesicant properties, acute and cardiac toxicities, and antitumor efficacy of doxorubicin J.A.E. Balazsovits, L.D. Mayer, Marcel B. Bally, Cancer Chemotherapy and Pharmacology Lipid PreparationNanomedicineDrug TargetingCardiac ToxicitiesEngineering	1989	121
Phase I Study of Liposomal Vincristine Karen A. Gelmon, A. Tolcher, Abdelaziz A Diab, Journal of Clinical Oncology	1999	111
Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine:daunorubicin, in patients with advanced leukemia Eric J. Feldman, Jonathan E. Kolitz, J M Trang, Leukemia Research Pharmaceutical ScienceAdvanced LeukemiaMedicineMolar Ratio FormulationPharmacotherapy	2012	98

Page 1